425: Strive & Semler Scientific Merger Communication

Strive, Inc. reposted a communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• A communication was reposted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on September 26, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the transaction.
• Forward-looking statements cover the outlook and expectations of both companies, strategic and financial benefits, timing of closing, and successful integration of businesses.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and other relevant SEC documents before making any voting or investment decisions.
• Strive, Semler Scientific, and certain of their directors, executive officers, and employees may be considered participants in the solicitation of proxies.
• This communication does not constitute an offer to sell or solicit an offer to buy securities or a solicitation of any vote or approval.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural communication about a proposed merger, heavily weighted with cautionary forward-looking statements and risks, which is standard for such announcements. It doesn't present overwhelmingly positive or negative news, but rather outlines the process and potential challenges.

Positives

• Proposed transaction aims for strategic benefits for the combined company.
• Proposed transaction aims for financial benefits for the combined company.
• Anticipated cost savings are expected from the proposed transaction.
• Anticipated strategic gains are expected from the proposed transaction.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from Strive's or Semler Scientific's customers could occur.
• Changes to business or employee relationships may result from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies.
• Risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed transaction, including cost savings and successful integration, though these are subject to significant risks and uncertainties that could cause actual results to differ materially from expectations.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com on September 26, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

This filing is a standard procedural communication related to a proposed merger, common in industries undergoing consolidation or strategic shifts. The explicit mention of 'Bitcoin treasury strategies' and 'digital assets' suggests a potential integration of digital asset management into the combined entity's strategy, reflecting a growing trend in certain financial and technology sectors.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Shareholders of Strive: Potential dilution from the issuance of additional Class A common stock.
• Shareholders of Semler Scientific: Will be asked to approve the proposed transaction and are urged to review merger documents.
• Customers of Strive and Semler Scientific: Potential for adverse reactions.
• Employees of Strive and Semler Scientific: Potential for changes to business or employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and other relevant documents when they become available.

Key Dates

Recommendation

This filing is a procedural communication regarding a proposed business combination, primarily serving as a cautionary statement about forward-looking information and outlining the associated risks. It does not provide new financial results or operational updates that would warrant a strong buy or sell recommendation. Investors should hold and await further detailed information, particularly the Form S-4 and Information Statement/Proxy Statement/Prospectus, to fully assess the strategic rationale, financial implications, and integration plans before making a definitive investment decision. The numerous risks highlighted suggest a cautious approach is warranted.

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, risks, Bitcoin, digital assets, corporate governance, proxy solicitation, S-4, financial reporting